Shiyong Xin

4PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 12, 2026
MYC promotes the progression of prostate cancer by regulating CD47 to induce an immunosuppressive microenvironment.

Shiyong Xin, Junjie Su, Le Zhao

|Feb 04, 2026
Targeting NXPH4/ALDH1L2 signaling suppresses enzalutamide resistance in prostate cancer.

Xianchao Sun, Ying Zhang, Wei Zhang

|Aug 04, 2023
A novel model based on disulfidptosis-related genes to predict prognosis and therapy of bladder urothelial carcinoma.

Shiyong Xin, Ruixin Li, Junjie Su

Pageof 1